Correlation Between Neurocrine Biosciences and Transocean

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Transocean at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Transocean into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and Transocean, you can compare the effects of market volatilities on Neurocrine Biosciences and Transocean and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Transocean. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Transocean.

Diversification Opportunities for Neurocrine Biosciences and Transocean

0.6

Correlation Coefficient

Neurocrine Biosciences  Transocean

Poor diversification

The 3 months correlation between Neurocrine and Transocean is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Transocean in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transocean and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Transocean. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transocean has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Transocean go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Transocean

Assuming the 90 days trading horizon Neurocrine Biosciences is expected to generate 1.42 times less return on investment than Transocean. But when comparing it to its historical volatility, Neurocrine Biosciences is 2.15 times less risky than Transocean. It trades about 0.2 of its potential returns per unit of risk. Transocean is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  1,297  in Transocean on April 25, 2025 and sell it today you would earn a total of  394.00  from holding Transocean or generate 30.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Neurocrine Biosciences  vs.  Transocean

Neurocrine Biosciences

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental drivers, Neurocrine Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Transocean

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Transocean are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, Transocean sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neurocrine Biosciences and Transocean

The main advantage of trading using opposite Neurocrine Biosciences and Transocean positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Transocean can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transocean will offset losses from the drop in Transocean's long position.

The idea behind Neurocrine Biosciences and Transocean pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.